Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Viscosity Method Development Using Brookfield Viscometer – V 2.0

Posted on By

Analytical Method Development: SOP for Viscosity Method Development Using Brookfield Viscometer – V 2.0

Standard Operating Procedure for Viscosity Method Development Using Brookfield Viscometer in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/256/2025
Supersedes SOP/AMD/256/2022
Page No. Page 1 of 12
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To define the procedure for developing and validating a method to measure the viscosity of semi-solid formulations such as creams, ointments, and gels using

a Brookfield viscometer.

2. Scope

This SOP applies to the Analytical Method Development (AMD) department responsible for determining the viscosity of pharmaceutical semi-solid products during product development, technology transfer, and stability studies.

3. Responsibilities

  • Analytical Scientist: Develops the viscosity method and performs measurements using the appropriate spindle and speed.
  • QC Analyst: Assists in equipment calibration, sample handling, and result verification.
  • QA Executive: Reviews method validation data and ensures documentation compliance.
See also  Analytical Method Development: SOP for Tonicity Testing Method Development - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that the viscosity method is validated, scientifically justified, and suitable for regulatory and commercial use.

5. Procedure

5.1 Instrument and Accessories

  1. Brookfield Viscometer (DV-E, DV1, or equivalent)
  2. Appropriate spindles (e.g., LV series for low viscosity or RV for high viscosity)
  3. Temperature-controlled water bath (if required)
  4. Standard viscosity calibration fluids

5.2 Instrument Calibration

  1. Calibrate viscometer annually or as per manufacturer’s guidelines using certified viscosity standards.
  2. Record calibration data in the instrument log (Annexure-2).

5.3 Sample Preparation

  1. Ensure the sample is free from air bubbles and at specified temperature (e.g., 25 ± 0.5°C).
  2. Use a wide-mouth beaker and fill to appropriate depth to cover the spindle immersion mark.
  3. Allow the sample to equilibrate in a temperature-controlled environment for 15 minutes.

5.4 Method Development Parameters

  1. Identify the appropriate spindle and speed to give full-scale torque between 10% and 90%.
  2. Record spindle type, rotational speed (RPM), and time of measurement (usually 30–60 seconds).
  3. If thixotropic behavior is observed, use continuous ramping or hysteresis loop profiling.
See also  Analytical Method Development: Development of Sterility Test Protocol - V 2.0

5.5 Viscosity Measurement

  1. Assemble the viscometer and select spindle based on expected viscosity range.
  2. Immerse spindle into the sample without trapping air bubbles.
  3. Start rotation and allow reading to stabilize before recording.
  4. Record readings in centipoise (cP) or mPa·s.

5.6 Acceptance Criteria

  • RSD of triplicate readings ≤ 3%
  • Viscosity within predefined specification range, e.g., 10,000–50,000 cP

5.7 Method Validation Parameters

  1. Precision: Evaluate intra- and inter-day RSD (≤ 3%)
  2. Ruggedness: Compare results between analysts, instruments, and batches
  3. Robustness: Assess impact of slight variations in temperature, speed, and spindle

6. Abbreviations

  • cP: Centipoise
  • RPM: Revolutions Per Minute
  • RSD: Relative Standard Deviation
  • QA: Quality Assurance

7. Documents

  1. Viscosity Measurement Log – Annexure-1
  2. Calibration Record – Annexure-2
  3. Method Validation Report – Annexure-3

8. References

  • USP <912>: Viscosity
  • Brookfield Engineering Operating Manual
  • ICH Q2(R1): Validation of Analytical Procedures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Ritika Mehra Ajay Deshmukh Sunita Reddy
Designation Analytical Scientist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Viscosity Measurement Log

Sample ID Spindle Speed (RPM) Reading 1 (cP) Reading 2 (cP) Reading 3 (cP) Average Status
VIS-256-01 Spindle #4 10 25300 25120 25250 25223 Pass

Annexure-2: Calibration Record

Date Instrument ID Standard Used Expected cP Observed cP Status
21/05/2025 BV-01 Brookfield Std. Fluid 12,000 11,850 Pass

Annexure-3: Method Validation Report

The viscosity method for gel-based product G-256 was validated across 3 days. RSD values were ≤ 1.8%, linearity across torque range was r = 0.998. Method found robust across spindle variations and temperature changes from 24–26°C.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Updated to include RSD criteria and spindle selection rationale Annual SOP Review Sunita Reddy
05/03/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: SOP for Identification of Cream Base Components via FTIR - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Quality Control: SOP for Reviewing QC Test Results before Product Release – V 2.0
Next Post: Gel Manufacturing: SOP for Operating High-Shear Mixers – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version